Glucuronidation does not suppress the estrogenic activity of quercetin in yeast and human breast cancer cell model systems.

[1]  S. Ottonello,et al.  Anti-estrogenic activity of a human resveratrol metabolite. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[2]  F. A. Resende,et al.  Evaluation of Estrogenic Potential of Flavonoids Using a Recombinant Yeast Strain and MCF7/BUS Cell Proliferation Assay , 2013, PloS one.

[3]  Dongyan Zhang,et al.  Quercetin and quercetin-3-O-glucuronide are equally effective in ameliorating endothelial insulin resistance through inhibition of reactive oxygen species-associated inflammation. , 2013, Molecular nutrition & food research.

[4]  A. Rodriguez-Mateos,et al.  Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. , 2013, Antioxidants & redox signaling.

[5]  G. Pasinetti,et al.  Identification of brain‐targeted bioactive dietary quercetin‐3‐O‐glucuronide as a novel intervention for Alzheimer's disease , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  D. Ardigò,et al.  Quercetin-3-O-glucuronide affects the gene expression profile of M1 and M2a human macrophages exhibiting anti-inflammatory effects. , 2012, Food & function.

[7]  Young In Park,et al.  Estrogenic/antiestrogenic activities of a Epimedium koreanum extract and its major components: in vitro and in vivo studies. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[8]  G. Rimbach,et al.  Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. , 2011, The Journal of nutritional biochemistry.

[9]  M. Clifford,et al.  Bioavailability of dietary flavonoids and phenolic compounds. , 2010, Molecular aspects of medicine.

[10]  H. Patisaul,et al.  The pros and cons of phytoestrogens , 2010, Frontiers in Neuroendocrinology.

[11]  D. Murphy,et al.  Estrogen therapy and Alzheimer's dementia , 2010, Annals of the New York Academy of Sciences.

[12]  T. Inakuma,et al.  Dietary quercetin inhibits bone loss without effect on the uterus in ovariectomized mice , 2009, Journal of Bone and Mineral Metabolism.

[13]  M. Marino,et al.  Quercetin-induced apoptotic cascade in cancer cells: antioxidant versus estrogen receptor alpha-dependent mechanisms. , 2009, Molecular nutrition & food research.

[14]  A. Bast,et al.  Health effects of quercetin: from antioxidant to nutraceutical. , 2008, European journal of pharmacology.

[15]  J. Heindel,et al.  Effects of endocrine disruptors on obesity. , 2008, International journal of andrology.

[16]  G. S. Pope,et al.  Effect of sulphation on the oestrogen agonist activity of the phytoestrogens genistein and daidzein in MCF-7 human breast cancer cells , 2008, The Journal of endocrinology.

[17]  J. Terao,et al.  Effects of quercetin and quercetin 3‐glucuronide on the expression of bone sialoprotein gene , 2007, Journal of cellular biochemistry.

[18]  P. Ascenzi,et al.  Structure–function relationship of estrogen receptor α and β: Impact on human health , 2006 .

[19]  C. Edwards,et al.  Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions , 2006, British Journal of Nutrition.

[20]  G. Rimbach,et al.  Daidzein-sulfate metabolites affect transcriptional and antiproliferative activities of estrogen receptor-beta in cultured human cancer cells. , 2005, The Journal of nutrition.

[21]  A. Murk,et al.  The stimulation of cell proliferation by quercetin is mediated by the estrogen receptor. , 2005, Molecular nutrition & food research.

[22]  J. Mazière,et al.  Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. , 2004, Biochemical pharmacology.

[23]  Andrea Bonanome,et al.  Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. , 2002, The American journal of medicine.

[24]  M. Denison,et al.  Relationship between Estrogen Receptor-Binding and Estrogenic Activities of Environmental Estrogens and Suppression by Flavonoids , 2002, Bioscience, biotechnology, and biochemistry.

[25]  Rui M. Rocha,et al.  Interactions of Flavonoids with Iron and Copper Ions: A Mechanism for their Antioxidant Activity , 2002, Free radical research.

[26]  S. Andò,et al.  Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. , 2001, Molecular pharmacology.

[27]  A. Maggi,et al.  Engineering of a mouse for the in vivo profiling of estrogen receptor activity. , 2001, Molecular endocrinology.

[28]  J. Terao,et al.  Identification of quercetin 3-O-beta-D-glucuronide as an antioxidative metabolite in rat plasma after oral administration of quercetin. , 2001, Free radical biology & medicine.

[29]  D. Birt,et al.  Dietary agents in cancer prevention: flavonoids and isoflavonoids. , 2001, Pharmacology & therapeutics.

[30]  D. Barron,et al.  Human metabolism of dietary flavonoids: Identification of plasma metabolites of quercetin , 2001, Free radical research.

[31]  L Fioravanti,et al.  The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function , 1999, British Journal of Cancer.

[32]  P. Murphy,et al.  Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations. , 1999, The Journal of nutrition.

[33]  J. Corton,et al.  Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.

[34]  G. Lescoat,et al.  Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. , 1993, Biochemical pharmacology.

[35]  R. Coombes,et al.  Characterization of estrogen receptor messenger RNA in human breast cancer. , 1987, Cancer research.

[36]  T Nishihara,et al.  New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator. , 1999, Toxicology and applied pharmacology.

[37]  D. Zava,et al.  Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. , 1997, Nutrition and cancer.